Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02668848 : The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.
PhasePhase 2/Phase 3
AgesMin: N/A Max: N/A
Inclusion Criteria:

1. Acute ischemic stroke diagnosed by the clinical presentations and brain imaging is
confirmed by a stroke care specialist,

2. has a measurable neurologic deficit according to the National Institutes of Health
Stroke Scale (NIHSS),

3. the time between the onset of neurological symptoms and starting therapy are less
than 48 hours,

4. admission BUN/Cr<15

Exclusion Criteria:

1. no informed consent obtained,

2. initial NIHSS >15,

3. prepared for or received fibrinolytic therapy,

4. prepared for or received surgical intervention with 14 days,

5. congestive heart failure according to past history or Framingham criteria,

6. history of liver cirrhosis or severe liver dysfunction (ALT or AST > x 3 upper normal

7. admission blood Cr >2 mg/dl,

8. initial blood pressure SBP<90 mmHg,

9. fever with core temperature >=38°C,

10. indication of diuretics for fluid overload,

11. any conditions needed more aggressive hydration or blood transfusion,

12. cancer under treatment,

13. life expectancy or any reasons for follow-up < 3 months
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557